Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
| Class:Id | LiteratureReference:1228027 |
|---|
| _displayName | EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy |
|---|
| _timestamp | 2011-03-16 17:46:54 |
|---|
| author | [Person:1228022] Paez, JG
[Person:1181013] Jänne, PA
[Person:1228028] Lee, JC
[Person:1228029] Tracy, S
[Person:1169426] Greulich, Heidi
[Person:1228021] Gabriel, S
[Person:1228017] Herman, P
[Person:1228018] Kaye, FJ
[Person:1228024] Lindeman, N
[Person:202244] Boggon, TJ
[Person:1228026] Naoki, K
[Person:1228019] Sasaki, H
[Person:195965] Fujii, Y
[Person:202355] Eck, MJ
[Person:188357] Sellers, WR
[Person:1228030] Johnson, BE
[Person:1169419] Meyerson, M |
|---|
| created | [InstanceEdit:1228023] Orlic-Milacic, Marija, 2011-03-16 |
|---|
| journal | Science |
|---|
| pages | 1497-500 |
|---|
| pubMedIdentifier | 15118125 |
|---|
| title | EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy |
|---|
| volume | 304 |
|---|
| year | 2004 |
|---|
| (literatureReference) | [Reaction:1225951] SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with ligand-responsive p-6Y-EGFR mutants) [Homo sapiens]
[Reaction:1225957] SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with phosphorylated SHC1 and ligand-responsive p-6Y-EGFR mutants) [Homo sapiens]
[Reaction:1226014] Conversion of PIP2 to PIP3 by PI3K bound to ligand-responsive p-6Y-EGFR mutants [Homo sapiens]
[EntityWithAccessionedSequence:1228025] EGFR E746_S752delinsV [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:1228034] EGFR L747_A750delinsP [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:1228039] p-6Y-EGFR E746_S752delinsV [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:1228044] p-6Y-EGFR L747_A750delinsP [plasma membrane] [Homo sapiens] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy (1228027)
